Table 3 Univariate and multivariate analyses for uniEPMR.
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
Crude OR | 95% CI | p-value† | Adjusted OR | 95% CI | p-value† | |
Lesion size | ||||||
20–29 mm vs. 10–19 mm | 3.05 | 2.21–4.21 | < 0.0001 | 2.52 | 1.82–3.49 | < 0.0001 |
30 mm- vs. 10–19 mm | 14.71 | 7.65–28.29 | < 0.0001 | 11.83 | 6.80–20.60 | < 0.0001 |
Specialist | 0.99 | 0.77–1.28 | 0.9503 | 1.31 | 0.98–1.76 | 0.0713 |
Experienced cases | ||||||
60–150 cases vs. 0–50 cases | 1.02 | 0.64–1.64 | 0.9229 | 0.68 | 0.41–1.14 | 0.1462 |
160–250 cases vs. 0–50 cases | 0.71 | 0.43–1.16 | 0.1727 | 0.43 | 0.25–0.74 | 0.0025 |
260 cases vs. 0–50 cases | 1 | 0.65–1.54 | 0.9825 | 0.75 | 0.47–1.22 | 0.2535 |
Lesions on the folds | 4.79 | 3.38–6.79 | < 0.0001 | 3.39 | 2.52–4.55 | < 0.0001 |
Non-polypoid lesion | 4.37 | 3.08–6.20 | < 0.0001 | 3.06 | 2.25–4.14 | < 0.0001 |
Histological diagnosis | ||||||
IMC vs. adenoma | 1.97 | 1.45–2.67 | < 0.0001 | 1.62 | 1.15–2.29 | 0.0058 |
SM-invasive cancer vs. adenoma | 2.05 | 1.27–3.31 | 0.0034 | 1.63 | 0.95–2.81 | 0.0765 |
Localization of the lesions | ||||||
C vs. S | 4.63 | 2.88–7.45 | < 0.0001 | 2.72 | 1.64–4.51 | 0.0001 |
A vs. S | 2.43 | 1.68–3.54 | < 0.0001 | 1.49 | 0.98–2.27 | 0.0592 |
T vs. S | 2.54 | 1.71–3.77 | < 0.0001 | 1.77 | 1.16–2.71 | 0.008 |
D vs. S | 1.79 | 1.04–3.10 | 0.0363 | 1.5 | 0.81–2.78 | 0.1977 |
R vs. S | 2.1 | 1.38–3.20 | 0.0005 | 2.05 | 1.31–3.20 | 0.0017 |
